FTRE
FTRE
NASDAQ · Life Sciences Tools & Services

Fortrea Holdings Inc

$21.96
+1.50 (+7.33%)
As of Nov 7, 10:02 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.04B
Net Income
-1,100,121,569
Gross Margin
18.5%
Profit Margin
-36.2%
Rev Growth
-4.2%
D/E Ratio
1.87
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 18.5% 18.5% 33.3% 33.3%
Operating Margin -32.0% -28.8% 4.2% 4.3%
Profit Margin -36.2% -34.4% 3.9% 4.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.04B 3.17B 1.34B 1.39B
Gross Profit 562.03M 586.61M 445.86M 460.95M
Operating Income -973,372,043 -914,345,933 56.52M 59.15M
Net Income -1,100,121,569 -1,033,409,260 52.33M 61.93M
Gross Margin 18.5% 18.5% 33.3% 33.3%
Operating Margin -32.0% -28.8% 4.2% 4.3%
Profit Margin -36.2% -34.4% 3.9% 4.5%
Rev Growth -4.2% -4.2% +7.6% +19.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 690.16M 690.16M 574.49M 632.75M
Total Equity 369.41M 369.41M 884.45M 884.57M
D/E Ratio 1.87 1.87 0.65 0.72
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -886,386,513 -878,892,795 75.93M 85.51M
Free Cash Flow — — 62.53M 81.90M